Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
CalciMedica's CRAC channel inhibition platform and Auxora™ show promise for multiple uses
This team's expertise is crucial for advancing Prelude's drug pipeline
the AI in drug discovery market was about $1
with SLA-backed latency targets under 2 seconds and automated exception workflows
Covalto's data-driven approach is a competitive advantage in the fintech space
HELCIM INC. BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_174 CalciMedica's CRAC channel inhibition platformWhat is included in the product Detailed Word Document Helcim's BMC is a comprehensive model reflecting real operations. Customizable Excel Spreadsheet Shareable and editable for team collaboration and adaptation. Full Version Awaits Business Model Canvas You're viewing the live Business Model Canvas you'll receive from Helcim Inc. after purchase. This preview is a direct representation of the final, ready to use document. The complete, unlocked file
US$ 182.97
US$ 163.95
US$ 125.97
US$ 110.95
US$ 16.99
US$ 16.99
US$ 44.95
US$ 19.00
US$ 14.95
US$ 5800.00
US$ 24.00
US$ 14.50
US$ 59.00
US$ 14.00
US$ 12.00
US$ 242.50
